{"id":{"repo_id":"mcmaster","oai_identifier":"oai:macsphere.mcmaster.ca:11375/33735"},"canonical_url":"https://search.ndltd.org/etd/mcmaster/oai:macsphere.mcmaster.ca:11375/33735","repository":{"repo_id":"mcmaster","name":"McMaster University","base_url":"https://macsphere.mcmaster.ca/server/oai/request"},"display":{"title":"Understanding the role of nonsense-mediated mRNA decay in neurodegeneration using Caenorhabditis elegans","abstract":"Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. The only treatment options available simply mitigate existing symptoms as opposed to treating the root cause of disease. A molecular hallmark of AD is hyperphosphorylation of the microtubule-associated protein tau. This protein promotes microtubule stability, axonal transport, and synaptic efficiency. However, when tau is hyperphosphorylated, it dislodges the microtubule, and self-aggregates with other tau molecules, hindering its functions. Our lab found that when a disease associated form of tau is expressed, transcripts that are normally degraded through nonsense-mediated decay (NMD) begin to accumulate. NMD ensures that transcripts containing premature termination codons are degraded before peptide synthesis. In using the model organism C. elegans, we are working to understand the mechanism by which NMD is shut off in the presence of pathological forms of tau. To monitor NMD in neurons, GFP reporters to measure pathway activity have been generated and validated. Transcripts from these reporters will normally be degraded by NMD, therefore, fluorescence quantification can be used as an indicator of NMD activity. Through genetic screening using these reporter strains, genes relating to the ‘endosomal sorting complex required for transport (ESCRT) complex show evidence of reducing NMD activity when knocked down. The goal of this project is to discover the intermediate steps by which toxic forms of tau contribute to NMD inactivation. Future work involves characterization of an ESCRT reporter strain in C. elegans and observing how the complex functions in the presence of pathological tau.","abstract_html":"Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. The only treatment options available simply mitigate existing symptoms as opposed to treating the root cause of disease. A molecular hallmark of AD is hyperphosphorylation of the microtubule-associated protein tau. This protein promotes microtubule stability, axonal transport, and synaptic efficiency. However, when tau is hyperphosphorylated, it dislodges the microtubule, and self-aggregates with other tau molecules, hindering its functions. Our lab found that when a disease associated form of tau is expressed, transcripts that are normally degraded through nonsense-mediated decay (NMD) begin to accumulate. NMD ensures that transcripts containing premature termination codons are degraded before peptide synthesis. In using the model organism C. elegans, we are working to understand the mechanism by which NMD is shut off in the presence of pathological forms of tau. To monitor NMD in neurons, GFP reporters to measure pathway activity have been generated and validated. Transcripts from these reporters will normally be degraded by NMD, therefore, fluorescence quantification can be used as an indicator of NMD activity. Through genetic screening using these reporter strains, genes relating to the ‘endosomal sorting complex required for transport (ESCRT) complex show evidence of reducing NMD activity when knocked down. The goal of this project is to discover the intermediate steps by which toxic forms of tau contribute to NMD inactivation. Future work involves characterization of an ESCRT reporter strain in C. elegans and observing how the complex functions in the presence of pathological tau.","abstract_has_math":false,"creators":["Di Francesco, Sofia Rachele"],"institution":null,"degree_name":null,"degree_level":null,"degree_discipline":null,"degree_department":"Biochemistry and Biomedical Sciences","school":null,"contributors":[],"advisors":["MacNeil, Lesley"],"committee_chairs":[],"committee_members":[],"year":2026,"date_issued":"2026","date_published":"2026","updated_at":"2026-11-18T19:40:11Z","subjects":[],"languages":[],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://doi.org/10.71548/25505"],"render_values":[{"text":"https://doi.org/10.71548/25505","href":"https://doi.org/10.71548/25505","code":true}]}],"person_identifier_entries":[]},"links":{"outbound_url":"https://hdl.handle.net/11375/33735","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/11375/33735","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://macsphere.mcmaster.ca/server/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Amacsphere.mcmaster.ca%3A11375%2F33735","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["MacNeil, Lesley"]},{"key":"dc:contributor.department","label":"Department","values":["Biochemistry and Biomedical Sciences"]},{"key":"dc:creator","label":"Author","values":["Di Francesco, Sofia Rachele"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-10-06T18:21:03Z"]},{"key":"dc:date.issued","label":"Date","values":["2026"]},{"key":"dc:type","label":"Dc Type","values":["Thesis"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/11375/33735","https://doi.org/10.71548/25505"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description.abstract","label":"Abstract","values":["Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. The only treatment options available simply mitigate existing symptoms as opposed to treating the root cause of disease. A molecular hallmark of AD is hyperphosphorylation of the microtubule-associated protein tau. This protein promotes microtubule stability, axonal transport, and synaptic efficiency. However, when tau is hyperphosphorylated, it dislodges the microtubule, and self-aggregates with other tau molecules, hindering its functions. Our lab found that when a disease associated form of tau is expressed, transcripts that are normally degraded through nonsense-mediated decay (NMD) begin to accumulate. NMD ensures that transcripts containing premature termination codons are degraded before peptide synthesis. In using the model organism C. elegans, we are working to understand the mechanism by which NMD is shut off in the presence of pathological forms of tau. To monitor NMD in neurons, GFP reporters to measure pathway activity have been generated and validated. Transcripts from these reporters will normally be degraded by NMD, therefore, fluorescence quantification can be used as an indicator of NMD activity. Through genetic screening using these reporter strains, genes relating to the ‘endosomal sorting complex required for transport (ESCRT) complex show evidence of reducing NMD activity when knocked down. The goal of this project is to discover the intermediate steps by which toxic forms of tau contribute to NMD inactivation. Future work involves characterization of an ESCRT reporter strain in C. elegans and observing how the complex functions in the presence of pathological tau."]},{"key":"dc:description.degree","label":"Dc Description Degree","values":["Master of Science (MSc)"]},{"key":"dc:title","label":"Title","values":["Understanding the role of nonsense-mediated mRNA decay in neurodegeneration using Caenorhabditis elegans"]},{"key":"others:access_status","label":"Others Access Status","values":["embargo"]}]}],"canonical_facts":{"dc:contributor.advisor":["MacNeil, Lesley"],"dc:contributor.department":["Biochemistry and Biomedical Sciences"],"dc:creator":["Di Francesco, Sofia Rachele"],"dc:date.accessioned":["2026-10-06T18:21:03Z"],"dc:date.issued":["2026"],"dc:description.abstract":["Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that affects millions of people worldwide. The only treatment options available simply mitigate existing symptoms as opposed to treating the root cause of disease. A molecular hallmark of AD is hyperphosphorylation of the microtubule-associated protein tau. This protein promotes microtubule stability, axonal transport, and synaptic efficiency. However, when tau is hyperphosphorylated, it dislodges the microtubule, and self-aggregates with other tau molecules, hindering its functions. Our lab found that when a disease associated form of tau is expressed, transcripts that are normally degraded through nonsense-mediated decay (NMD) begin to accumulate. NMD ensures that transcripts containing premature termination codons are degraded before peptide synthesis. In using the model organism C. elegans, we are working to understand the mechanism by which NMD is shut off in the presence of pathological forms of tau. To monitor NMD in neurons, GFP reporters to measure pathway activity have been generated and validated. Transcripts from these reporters will normally be degraded by NMD, therefore, fluorescence quantification can be used as an indicator of NMD activity. Through genetic screening using these reporter strains, genes relating to the ‘endosomal sorting complex required for transport (ESCRT) complex show evidence of reducing NMD activity when knocked down. The goal of this project is to discover the intermediate steps by which toxic forms of tau contribute to NMD inactivation. Future work involves characterization of an ESCRT reporter strain in C. elegans and observing how the complex functions in the presence of pathological tau."],"dc:description.degree":["Master of Science (MSc)"],"dc:identifier.uri":["https://hdl.handle.net/11375/33735","https://doi.org/10.71548/25505"],"dc:title":["Understanding the role of nonsense-mediated mRNA decay in neurodegeneration using Caenorhabditis elegans"],"dc:type":["Thesis"],"others:access_status":["embargo"]},"updated_at":"2026-11-18T19:40:11Z"}